Background
Noninvasive assessment of altered myocardial tissue in patients with genetic mutations associated with hypertrophic cardiomyopathy (HCM) remains a challenge. In this pilot study, we evaluated whether a novel echocardiography-based assessment of myocardial microstructure, the signal intensity coefficient (SIC), could detect tissue-level alterations in HCM sarcomere mutation carriers with and without left ventricular hypertrophy (LVH).
Methods and Results
We studied 3 groups of genotyped individuals: sarcomere mutation carriers with LVH (clinical HCM; N=36), mutation carriers with normal LV wall thickness (subclinical HCM; N=28), and healthy controls (N=10). We compared measurements of echocardiographic SIC with validated assessments of cardiac microstructural alteration, including CMR measures of interstitial fibrosis (extracellular volume fraction, ECV), as well as serum biomarkers (NTproBNP, hs-cTnI, and PICP). In age-, sex-, and familial relation-adjusted analyses, the SIC was quantitatively different in subjects with overt HCM, subclinical HCM, and healthy controls (P<0.001). Compared to controls, the SIC was 61% higher in overt HCM and 47% higher in subclinical HCM (P<0.001 for both). The SIC was significantly correlated with ECV (r=0.72; P<0.01), with LV mass and E’ velocity (r=0.45, −0.60, respectively; P<0.01 for both), as well as with serum NT-proBNP levels (r=0.36; P<0.001).
Conclusions
Our findings suggest that the SIC could serve as a non-invasive quantitative tool for assessing altered myocardial tissue characteristics in patients with genetic mutations associated with HCM. Further studies are needed to determine whether the SIC could be used to identify subclinical changes in patients at risk for HCM and evaluating the effects of interventions.